NES ZIONA, Israel - QTREX Quantum Ltd. (NASDAQ:QTEX) announced today it received a purchase order from a Fortune 500 multinational company for an Additively Manufactured Electronics system and related materials, according to a press release statement. The announcement comes as the stock has surged over 400% in the past year, trading at $3.07 with a market capitalization of $133.8 million.
The customer is headquartered in the United States, and the AME system will be delivered to one of the customer’s sites outside the United States. The company did not disclose the financial terms of the order or identify the customer.
QTREX’s AME system is designed to create intricate structures with advanced materials and customized architectures in a single workflow. The company stated this capability is intended to enable higher complexity for applications where traditional manufacturing reaches its physical limits.
"Conventional manufacturing is reaching its limits in advanced electronics," said Dagi Ben-Noon, CEO of QTREX. "Our AME platform provides capabilities that conventional technologies simply cannot replicate, and that advantage is most visible in quantum connectivity, where the density, materials integration and design freedom required for scale cannot be achieved any other way."The company remains unprofitable with a loss of $0.45 per share over the last twelve months, though analysts forecast revenue growth of 165% for fiscal 2026. InvestingPro subscribers have access to 15 additional exclusive tips about QTEX, including detailed analysis of the company’s financial health and growth trajectory.
The company stated the order is expected to contribute to its upcoming financial results. QTREX indicated it is engaging with additional prospective customers and expects to provide further updates as its AME commercial pipeline advances.
QTREX Quantum Ltd. is a technology company focused on advanced connectivity and electronics manufacturing solutions. Following its acquisition of the AME platform, the company is developing quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, and other mission-critical environments. The company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms.
In other recent news, QTREX Quantum Ltd. announced a private placement agreement with an institutional investor, expected to generate approximately $10 million in gross proceeds. This transaction is anticipated to close around June 1, 2026, pending customary closing conditions. Additionally, the company has changed its name from Inspira Technologies Oxy B.H.N. Ltd. to QTREX Quantum Ltd., with shares set to trade under the new ticker symbol "QTEX."
QTREX also received a $580,000 order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems, following a successful clinical evaluation. Furthermore, a $596,000 purchase order was secured for an Additively Manufactured Electronics system from an Irish technological research university, with an upfront payment already received. The company has also delivered an AME system to a Tier-1 U.S. defense customer site, marking a significant milestone in its commercial agreements. These developments highlight QTREX’s active engagement with various sectors, including healthcare and defense.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
The fastest way to find out is with our Fair Value calculator. We use a mix of 17 proven industry valuation models for maximum accuracy. Get the bottom line for QTEX plus thousands of other stocks and find your next hidden gem with massive upside.